Parturient with corrected or uncorrected cardiac problem may undergo neuraxial anaesthesia for several reasons and in different trimesters. The altered physiological state in a parturient is further deranged in the presence of a cardiovascular lesion, producing the added risk to the parturient undergoing a neuraxial block. A detailed evaluation, knowledge regarding cardiovascular disease state, more vigilant monitoring, and a team approach can lead to a successful outcome.
INTRODUCTION
Heart disease is the third most common cause of maternal death, and 20% of the patients suffering from cardiac disease have severe haemodynamic instability related to the underlying cardiac problem. [1] Parturients with cardiac disease often undergo surgery and neuraxial anaesthesia for various reasons and in different trimesters. There are few reports in the literature describing the management of parturients with cardiac disease during neuraxial anaesthesia. This article reviews current data and discusses important aspects of heart disease in relevance to neuraxial anaesthesia in a parturient. As labour and delivery are the most important aspect of pregnancy, the major focus of this article is on this segment.
The physiological changes occurring in the cardiovascular system due to pregnancy are exaggerated in the presence of a cardiac lesion. [2, 3] These cardiovascular changes along with coagulation abnormalities may discourage the use of neuraxial blockade due to the sympathetic blockade produced with the resulting haemodynamic changes. The author searched electronic databases including the following: MedLine, PubMed, and the Cochrane Central register of controlled clinical trials (until June 2018) and applied the following search terms: neuraxial block, spinal and epidural anaesthesia (EA), heart disease, surgery, and pregnant patient. Only the relevant English literature reports are considered in this review.
Approximately 60%-80% of parturients suffering from cardiac disease have congenital heart disease. [3] The commonest ones are tetralogy of Fallot, septal defects, and Eisenmenger's syndrome. Valvular heart disease comprises 15% cases, of which rheumatic mitral stenosis is the most common. Table 1 lists the common cardiac diseases in which successful use of neuraxial anaesthesia has been performed.
Normal pregnancy is associated with a 30%-50%
increase in blood volume, corresponding increase in plasma volume, and increase in cardiac output (CO). There is dilutional anaemia in spite of an increase in red cell mass over the third trimester because of an increase in plasma volume. [2] Stroke volume (SV) normally increases by 25%-35% with the remaining increase in CO being accounted for rise in heart rate (HR). Cardiac compromise with pulmonary oedema or biventricular failure may present in parturients earlier making the management of neuraxial anaesthesia more difficult. The early signs of cardiac compromise may become apparent in the first trimester and peak during second trimester, around 24 weeks when CO reaches the maximum and remains high till delivery 2. There is a progressive decrease in systemic vascular resistance (SVR) throughout gestation, and hence mean arterial pressure (MAP) is preserved at normal values despite an increase in CO. This has importance in patients with aortic stenosis and those with right to left shunt lesions 3. During labour, CO further increases by 10%-20% due to pain, anxiety, and autotransfusion during uterine contractions. SV and HR increase and decrease with each contraction, with peaks as high as 50% above the prelabour values. In the immediate postpartum period, CO peaks as the evacuated uterus contracts and blood from myometrial veins is autotransfused into the systemic venous system and gradually decreases thereafter. After vaginal delivery, the increase in CO and SV persists for 60-90 min, whereas HR decreases and blood pressure remains unchanged. After caesarean delivery, MAP remains unaltered and CO increases by 30%-50%, compared with predelivery values. These changes usually persist for 10-15 min and may precipitate pulmonary oedema in a decompensated heart 4. Hypercoagulability associated with pregnancy and the possible need for anticoagulation (e.g., patients in chronic atrial fibrillation (AF), prosthetic heart valve, and pulmonary thromboembolism) increase the risk of thrombosis or bleeding during neuraxial block. 
PREANAESTHETIC COSIDERATIONS
Parturient may require neuraxial anaesthesia during labour, delivery, or during the second trimester for procedures such as appendicectomy and ovarian cyst removal. Many reports have been published of successful administration of neuraxial blockade in parturient with cardiac disease coming for these procedures.
A detailed evaluation of the underlying cardiac problem including risk stratification is essential to consider for extensive monitoring/switch over to general anaesthesia and need for the help of a specialised team with experience of cardiovascular anaesthesia and intraoperative echocardiography. Pertinent cardiac testing (angiography, computerised tomography, or magnetic resonance imaging) apart from the routine echocardiography can determine the disorder that can affect the anaesthesia management. If available, serum β-type natriuretic peptide can be done for the parturient with the potential to develop heart failure during additional stress of surgery or anaesthesia. Patients with coartation of aorta are at increased risk of hypertension and ecampsia and neuraxial block should be avoided. Bleeding at the time of surgery/ delivery is more common in patients having cyanotic heart disease and/or on anticoagulation.
Infective endocarditis (IE) prophylaxis is needed in parturient with highest risk of IE, for example, those with prosthetic heart valve, history of IE before, and with some complex congenital lesions. In high-risk parturient, the preferred regime is ampicillin 1.5 mg/kg (maximum 120 mg) given intravenously 30 min before neuraxial block followed by ampicillin 1 g given intravenously/intramuscularly or amoxicillin 1 g given orally 6 h later. [4] The parturient needs to undergo some risk assessment scores, for example, CARPREG or ZAHARA and KHAIRY score to predict maternal cardiovascular events. [4] Patients with NYHA class >II, with a prior cardiac event (heart failure, stroke, or arrhythmia), critical mitral or aortic stenosis, severe left ventricular dysfunction, presence of a valve prosthesis or severe pulmonary regurgitation, and smoking history have an increased risk of both maternal and neonatal events during the course of pregnancy, labour, and delivery.
MONITORING
The extensiveness of monitoring depends on the severity of disease. In case of mild disease, monitoring includes noninvasive blood pressure measurement, electrocardiography (ECG), tocodynamometry, and foetal HR monitoring. In moderate to severe disease, the following additional monitoring aids may be applied depending on the availability. External defibrillator paddles should be placed before surgery in patients especially prone to intractable tachyarrhythmia. Filter in all intravenous lines in patients with shunt lesion to prevent paradoxical air embolism.
Pulse oxymetry: For rapid detection of desaturation, for example, tetralogy of Fallot's patient developing hypercyanotic spell.
ECG: Continuous five lead monitoring and ST segment monitoring is required for the detection of myocardial Mitral stenosis is the commonest lesion in pregnancy in our country. The symptoms depend on the severity of stenosis. However, the usual features are breathlessness, palpitation, chest pain, haemoptysis, pulmonary oedema, and thromboembolism. Knowing the severity of mitral stenosis (MS) is of paramount importance [ Table 4 ] to manage neuraxial block during labour and delivery. AF is common in parturients. An increase in HR decreases left ventricular filling time and thereby a fall in CO. This in combination with an increase in plasma volume as well as increase in preload (due to autotransfusion) following delivery may lead to pulmonary oedema. [5] The anaesthetic goals in these parturients are as follows: maintenance of acceptable HR, immediate treatment of acute AF, avoidance of aortocaval compression, maintenance of adequate venous return and normal blood pressure, Few details about the anticipated changes during neuraxial block in parturients with other cardiovascular disease, anaesthetic goals, and neuraxial block of choice that anaesthesiologists should know are described in Table 5 . [7] EA with or without fentanyl [8] adequate analgesia, as well as avoidance of hypoxia, hypercarbia, and acidosis.
Management of labour
Combined spinal epidural with intrathecal opioid such as fentanyl in the first stage followed by titrated dose of local anaesthetic (LA) in the second stage is beneficial to prevent stress-related tachycardia. The addition of fentanyl to dilute LA mixture enhances the quality of analgesia without contributing to the sympathetic blockade. The fall in SVR in this stage is managed with small bolus (50-100 µg) of phenylephrine. Ephedrine is avoided unless there is relative bradycardia (HR <70/min). For a critically ill parturient, opioid alone may be administered through epidural/intrathecal route. Adequate perineal and segmental analgesia reduce stress-induced increase in HR and potentiate the urge to push. This allows foetal descent to be accomplished by uterine contractions and avoiding the deleterious effects of Valsalva maneuver
Contd... [18] Minimise pain and stress (↓ incidence of myocardial ischemia) ↓ both preload and after load and thus a↓in myocardial work.
Early institution of CSE and EA [19] Omit epinephrine from test dose
Aortic aneurysms Segmental EA [20, 21] Cardiac [22] Sudden↓in SVR during SA leading to ↑ LVOTO and↓CO (contraindicated )
Low EA with or without an opioid with slow titration [23] [24] [25] Blocker to control HR Phenylephrine 50 µg increments to treat hypotension Diluted oxytocin is well-tolerated CEA/low EA [26] CEA/low EA Same as dilated cardiomyopathy Primary pulmonary hypertension (PAP>25 mmHg at rest) Avoid↓in SVR and ↑ in PVR Use vasopressor with caution under invasive monitoring RVF Thromboembolism EA Use oxytocin with caution [27] Contd...
SPECIAL GROUPS
Congenital cardiac lesions with a palliative surgery Successful palliative repair for a cardiac lesion before pregnancy is associated with some degree of maternal foetal risk even in best of hands. There are few reports available describing the successful use of EA or combined spinal epidural anaesthesia in these lesions. Table 6 represents the most common palliative intracardiac shunt in which successful pregnancy and delivery happened. [29] [30] [31] [32] Prosthetic heart valve and anticoagulation Parturient receives anticoagulation for several reasons, of which prosthetic heart valve is one. Chronic use of anticoagulation may give rise to thrombocytopaenia. The ideal level of platelets before neuraxial block should be more than 100,000/mm −3 according to different studies. There are some suggested durations for discontinuation of anticoagulant administration before and after neuraxial block and epidural catheter [ Table 7 ]. [33] [34] [35] [36] Postoperative analgesia in these cases is usually with an opioid or α-agonist or a combination of opioid and nonsteroidal anti-inflammatory drugs intravenously. Patient-controlled analgesia is an alternative mode of analgesia in these group of patients.
SUMMARY
Optimal management during neuraxial anaesthesia requires a thorough assessment of the anatomic and functional capacity of the diseased heart along with an analysis of how the described major physiologic changes are likely to affect the specific limitations imposed by the intrinsic disease, patient's tolerance to pain during labour or surgery, impact of uterine contraction-induced autotransfusion, postpartum changes induced by relief of vena caval obstruction, potential for postpartum haemorrhage, and use of uterine oxytocic agents.
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